Electrical storm: Definitions, clinical importance, and treatment

Current Opinion in Cardiology

Volumn 28, Issue 1, 2013, Pages 72-79

  Gao, Dongsheng ^a   Sapp, John L ^a  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

antiarrhythmic drugs; catheter ablation; electrical storm; implantable cardioverter defibrillator; ventricular tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DOFETILIDE; METOPROLOL; MEXILETINE; PROCAINAMIDE; QUINIDINE; SOTALOL;

CATHETER ABLATION; CLINICAL FEATURE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTRIC SHOCK; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DENERVATION; HEART INFARCTION; HEART RHYTHM; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERMETHOD COMPARISON; ISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK REDUCTION; TORSADE DES POINTES; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; VENTRICULAR TACHYCARDIA STORM;

ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; DISEASE MANAGEMENT; EARLY MEDICAL INTERVENTION; HEART; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RECURRENCE; SYMPATHECTOMY; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84871624841     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32835b59db     Document Type: Review

References (64)

1. Exner DV, Pinski SL, Wyse DG, et al. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 2001; 103:2066-2071. (Pubitemid 32373009)
2. Hariman RJ, Hu DY, Gallastegui JL, et al. Long-term follow-up in patients with incessant ventricular tachycardia. Am J Cardiol 1990; 66:831-836. (Pubitemid 20352263)
3. Hohnloser SH, Al-Khalidi HR, Pratt CM, et al. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J 2006; 27:3027-3032. (Pubitemid 44950447)
4. Bansch D, Bocker D, Brunn J, et al. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol 2000; 36:566-573. (Pubitemid 30624021)
5. Nademanee K, Taylor R, Bailey WE, et al. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000; 102:742-747. (Pubitemid 30643282)
6. Greene M, Newman D, Geist M, et al. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace 2000; 2:263-269.
7. Credner SC, Klingenheben T, Mauss O, et al. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 1998; 32:1909-1915. (Pubitemid 29010454)
8. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883. (Pubitemid 34984635)
9. Villacastin J, Almendral J, Arenal A, et al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation 1996; 93:753-762. (Pubitemid 26052462)
10. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359:1009-1017.
11. Wathen MS, Sweeney MO, DeGroot PJ, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001; 104:796-801. (Pubitemid 32762678)
12. Sweeney MO, Sherfesee L, DeGroot PJ, et al. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010; 7:353-360.
13. Dunbar SB, Dougherty CM, Sears SF, et al. Educational and psychological interventions toimprove outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement From the American Heart Association. Circulation 2012; 126:2146-2172.
14. Goldenberg I, Moss AJ, Hall WJ, et al. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation 2006; 113:2810-2817. (Pubitemid 44305293)
15. Kowey PR, Levine JH, Herre JM, et al. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 1995; 92:3255-3263.
16. Aliot EM, Stevenson WG, Almendral-Garrote JM, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm 2009; 6:886-933.
17. Verma A, Kilicaslan F, Marrouche NF, et al. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 2004; 15:1265-1270. (Pubitemid 39612632)
18. Brigadeau F, Kouakam C, Klug D, et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J 2006; 27:700-707.
19. Fries R, Heisel A, Huwer H, et al. Incidence and clinical significance of shortterm recurrent ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillator. Int J Cardiol 1997; 59:281-284. (Pubitemid 27240463)
20. Scheinman MM, Levine JH, Cannom DS, et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 1995; 92:3264-3272.
21. Wood MA, Simpson PM, Stambler BS, et al. Long-term temporal patterns of ventricular tachyarrhythmias. Circulation 1995; 91:2371-2377.
22. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, et al. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 2005; 7:184-192. (Pubitemid 40347865)
23. Sesselberg HW, Moss AJ, McNitt S, et al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 2007; 4:1395-1402. (Pubitemid 47578525)
24. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237. (Pubitemid 40110811)
25. Huang DT, Traub D. Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review. Prog Cardiovasc Dis 2008; 51:229-236.
26. Arya A, HaghjooM, Dehghani MR, et al. Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator. Am J Cardiol 2006; 97:389-392. (Pubitemid 43133056)
27. Zaugg CE, Wu ST, Barbosa V, et al. Ventricular fibrillation-induced intracellular Ca2 overload causes failed electrical defibrillation and postshock reinitiation of fibrillation. J Mol Cell Cardiol 1998; 30:2183-2192. (Pubitemid 28549971)
28. Joglar JA, Kessler DJ, Welch PJ, et al. Effects of repeated electrical defibrillations on cardiac troponin I levels. Am J Cardiol 1999; 83:270-272; A6. (Pubitemid 29047312)
29. Jones DL, Narayanan N. Defibrillation depresses heart sarcoplasmic reticulum calcium pump: a mechanism of postshock dysfunction. Am J Physiol 1998; 274 (1 Pt 2):H98-H105.
30. Hurst TM, Hinrichs M, Breidenbach C, et al. Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol 1999; 34:402-408.
31. Xie J, Weil MH, Sun S, et al. High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation 1997; 96:683-688. (Pubitemid 27329451)
32. RunsioM, Bergfeldt L, Brodin LA, et al. Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transoesophageal echocardiography. Eur Heart J 1997; 18:124-131. (Pubitemid 27105780)
33. Sears SE Jr, Conti JB. Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. Clin Cardiol 2003; 26:107-111. (Pubitemid 36330858)
34. Deneke T, Lemke B, Mugge A, et al. Catheter ablation of electrical storm. Expert Rev Cardiovasc Ther 2011; 9:1051-1058.
35. Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006; 295:165-171. (Pubitemid 43076435)
36. Brodine WN, Tung RT, Lee JK, et al. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). Am J Cardiol 2005; 96:691-695. (Pubitemid 41207315)
37. PacificoA, Hohnloser SH, Williams JH, et al. Prevention of implantabledefibrillator shocks by treatment with sotalol. D,L-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med 1999; 340:1855-1862. (Pubitemid 29272665)
38. Kettering K, Mewis C, Dornberger V, et al. Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2002; 25:1571-1576. (Pubitemid 35398916)
39. Seidl K, Hauer B, Schwick NG, et al. Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/ defibrillator. Am J Cardiol 1998; 82:744-748.
40. Dorian P, Al-Khalidi HR, Hohnloser SH, et al. Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial. J Am Coll Cardiol 2008; 52:1076-1083.
41. Roukoz H, Saliba W. Dofetilide: a new class III antiarrhythmic agent. Expert Rev Cardiovasc Ther 2007; 5:9-19. (Pubitemid 46157737)
42. O'Toole M, O'Neill G, Kluger J, et al. Efficacy and safety of oral dofetilide in patients with an implantable defibrillator: a multicenter study. Circulation 1999; 100(S2):794.
43. Pinter A, Akhtari S, O'Connell T, et al. Efficacy and safety of dofetilide in the treatment of frequent ventricular tachyarrhythmias after amiodarone intolerance or failure. J Am Coll Cardiol 2011; 57:380-381.
44. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 1989; 321:406-412.
45. Lee SD, Newman D, Ham M, Dorian P. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence. J Am Coll Cardiol 1997; 29:100-105. (Pubitemid 27028726)
46. Waleffe A, Mary-Rabine L, Legrand V, et al. Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia. Am Heart J 1980; 100 (6 Pt 1):788-793. (Pubitemid 11198869)
47. Bokhari F, Newman D, Greene M, et al. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year followup of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004; 110:112-116. (Pubitemid 38924577)
48. Tanner H, Hindricks G, Volkmer M, et al. Catheter ablation of recurrent scarrelated ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol 2010; 21:47-53.
49. Stevenson WG, Wilber DJ, Natale A, et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the Multicenter Thermocool Ventricular Tachycardia Ablation Trial. Circulation 2008; 118:2773-2782.
50. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007; 357:2657-2665.
51. Kuck KH, Schaumann A, Eckardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010; 375:31-40.
52. Sra J, Bhatia A, Dhala A, et al. Electroanatomically guided catheter ablation of ventricular tachycardias causing multiple defibrillator shocks. Pacing Clin Electrophysiol 2001; 24:1645-1652. (Pubitemid 33065524)
53. CarbucicchioC, Santamaria M, Trevisi N, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverterdefibrillators: short-and long-term outcomes in a prospective single-center study. Circulation 2008; 117:462-469.
54. Deneke T, Shin DI, LawoT, et al. Catheter ablation of electrical storm in a collaborative hospital network. Am J Cardiol 2011; 108:233-239.
55. Kozeluhova M, Peichl P, Cihak R, et al. Catheter ablation of electrical storm in patients with structural heart disease. Europace 2011; 13:109-113.
56. Silva RM, Mont L, Nava S, et al. Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004; 27:971-975. (Pubitemid 38970214)
57. Frankel DS, Mountantonakis SE, Robinson MR, et al. Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention. J Cardiovasc Electrophysiol 2011; 22: 1123-1128.
58. Blomberg S, Ricksten SE. Thoracic epidural anaesthesia decreases the incidence of ventricular arrhythmias during acute myocardial ischaemia in the anaesthetized rat. Acta Anaesthesiol Scand 1988; 32:173-178. (Pubitemid 18098958)
59. Kamibayashi T, Hayashi Y, MammotoT, et al. Thoracic epidural anesthesia attenuates halothane-induced myocardial sensitization todysrhythmogenic effect of epinephrine in dogs. Anesthesiology 1995; 82:129-134.
60. Schwartz PJ, Motolese M, Pollavini G, et al. Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions. J Cardiovasc Electrophysiol 2008; 3:2-16.
61. Schwartz PJ, Locati EH, Moss AJ, et al. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation 1991; 84:503-511.
62. Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 2004; 109:1826-1833. (Pubitemid 38509115)
63. Bourke T, Vaseghi M, Michowitz Y, et al. Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation 2010; 121:2255-2262.
64. Ajijola OA, Lellouche N, Bourke T, et al. Bilateral cardiac sympathetic denervation for the management of electrical storm. J Am Coll Cardiol 2012; 59:91-92.